Does Dr. MARIALIX ALEXANDRINO DE JESUS have financial conflicts of interest?

Dr. MARIALIX ALEXANDRINO DE JESUS (M.D.) has received a total of $211 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $211 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARIALIX ALEXANDRINO DE JESUS?

According to CMS Open Payments data, Dr. MARIALIX ALEXANDRINO DE JESUS received funding from ABBVIE ($125), MERCK SHARP & DOHME ($36), and GLAXOSMITHKLINE ($25).

Does Dr. MARIALIX ALEXANDRINO DE JESUS receive research grants or speaking fees?

Dr. MARIALIX ALEXANDRINO DE JESUS has received $211 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARIALIX ALEXANDRINO DE JESUS

M.D.Real-Time Hydrated

Specialty: Family Medicine, Geriatric Medicine

Practice Location: SAN JUAN, PR 00918

NPI Number: 1407296056

LIFETIME INDUSTRY VALUE

$211

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALEXANDRINO DE JESUS is a verified Family Medicine, Geriatric Medicine practitioner based in SAN JUAN, PR.

Between 2021 and 2025, Dr. ALEXANDRINO DE JESUS had an overall industry promotional and research financial footprint of $211 as recorded in the federal CMS Open Payments database.

$211 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALEXANDRINO DE JESUS's primary funding source is ABBVIE, which accounts for $125 (representing 59.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$125

59.3%

MERCK SHARP & DOHME

Rank 2

$36

17%

GLAXOSMITHKLINE

Rank 3

$25

11.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.